pirbuterol has been researched along with Cardiac Hypertrophy in 1 studies
pirbuterol: structure
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeppsson, AB | 1 |
| Waldeck, B | 1 |
| Widmark, E | 1 |
1 other study available for pirbuterol and Cardiac Hypertrophy
| Article | Year |
|---|---|
Further studies on the cardiomegaly induced by beta-adrenoceptor agonists.
Topics: Adrenergic beta-Agonists; Animals; Body Weight; Cardiomegaly; Ethanolamines; Guinea Pigs; Isoprotere | 1986 |